Regulation of mouse κ opioid receptor gene expression by retinoids

Journal of Neuroscience

Volumn 21, Issue 5, 2001, Pages 1590-1599

  Bi, Jing ^a   Hu, Xinli ^a   Loh, Horace H ^a   Wei, Li Na ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Central nervous system; Gene expression; Retinoic acid; Transgenic mouse; Vitamin A; opioid receptor

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; KAPPA OPIATE RECEPTOR; MESSENGER RNA; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EMBRYO; FEMALE; GENE EXPRESSION REGULATION; GENE REPRESSION; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RETINOL DEFICIENCY; TRANSGENIC MOUSE;

EID: 0035283184     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-05-01590.2001     Document Type: Article

References (45)

1. β-Endophin is a potent inhibitor of thymidine incorporation into DNA via μ and κ opioid receptors in fetal rat brain cell aggregates in culture
2. Characterization of a negative response DNA clement in the upstream region of cellular retinoic acid binding protein I gene of the mouse
3. Expression of μ, κ and δ opioid receptors in P19 mouse embryonal carcinoma cells
4. Opioid receptors: Pinning down the opiate targets
5. Distribution of neuropeptide receptors. New views of peptidergic neurotransmission made possible by antibodies to opioid receptors
6. Multiple opioid receptors: Ligand selectiv-ity profiles and binding signatures
7. 2+ mobilization, development and the antiproliferative effect of opioids
8. Promoter activity of mouse κ opioid receptor gene in transgenic mouse
9. Recent advances in molecular recognition and signal transduction of active peptides: Receptors for opioid peptides
10. Opioids: First lessons from knockout mice
11. 3H-U69593 as a binding ligand
12. Molecular biology and pharmacology of the cloned opioid receptors
13. Seizures and acute death attributable to hypovitaminosis A and suspected hypovitaminosis D in feeder pigs
14. Molecular cloning and characterization of a mouse nuclear orphan receptor expressed in embryos and testes
15. Cloning and characterization of mouse RIP140, a corepressor for nuclear receptor TR2
16. μ Opioid receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality
17. Studies of dual promoters of mouse κ opioid receptor gene
18. Vertebrate development: A nervous vitamin
19. Positional apoptosis during vertebrate CNS development in the absence of endogenous retinoids
20. The role of vitamin A in the development of the central nervous system
21. Mechanisms of action of drugs of abuse on the developing fetal brain
22. Opioid receptor mRNA expression in the rat CNS: Anatomical and functional implications
23. A genetic dissection of the retinoid signalling pathway in the mouse
24. Loss of morphine induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu opioid receptor gene
25. Retinoic acid and craniofacial development: Molecules and morphogenesis
26. Retinoic acid synthesis and hindbrain patterning in the mouse embryo
27. Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein
28. Vitamins and brain development
29. Opioids modulate cell division in the germinal zone of late embryonic neocortex
30. The prenatal developmental profile of expression of opioid peptides and receptors in the mouse brain
31. Behavioral and developmental changes associated with prenatal opiate receptor blockade
32. Disruption of the kappa opioid receptor gene in mice enhances sensitivity to chemical vesceral pain, impairs pharmacological actions of the selective kappa agonist U-50488 and attenuates morphine withdrawal
33. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine induced analgesia
34. Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice
35. Promoter and upstream regulatory activities of the mouse cellular retinoic acid binding protein-I gene
36. Molecular biology of opioid receptors and associate proteins
37. Regulation of the mouse cellular retinoic acid binding protein I gene by thyroid hormones and retinoids in transgenic mouse embryos and P19 cells
38. Post-transcriptional regulation of mouse κ opioid receptor expression
39. Vitamin A deficiency results in the dose dependent acquisition of anterior character and shortening of the caudal hindbrain of the rat embryo
40. Coactivator and corepressor complexes in nuclear receptor function
41. Increased brain size and cellular content in infant rats treated with an opiate antagonist
42. Endogenous opioid systems regulate cell proliferation in the developing rat brain
43. Developmental expression of the μ, κ, and δ opioid receptor mRNAs in mouse